Under-30s should be offered an alternative to the Oxford/AstraZeneca jab, the UK's vaccine regulator said this afternoon. What does this mean for the UK's roadmap? Katy Balls speaks to James Forsyth and Kate Andrews.
Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.
For more Spectator podcasts, go to spectator.co.uk/podcasts.
Contact us: podcast@spectator.co.uk
Hosted on Acast. See acast.com/privacy for more information.
